Liver Cancer News

CancerConnect liver cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of liver cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of liver cancer treatment and survivorship.

Share

Liver Cancer News


Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation (May 27, 2014)

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar®... Continue Reading

Liver Cancer Screening Improves Survival Rates Among Cirrhosis Patients, Says UT Southwestern Researcher (May 15, 2014)

A recent review by doctors at University of Texas Southwestern Medical Center has shown thatliver cancer survival rates could be improved if people with cirrhosis are more frequently screened for tumors... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

Coffee Cuts Risk of Liver Cancer (November 8, 2013)

Good news for coffee addicts—new research has found that regular coffee consumption can reduce the risk of liver cancer by 40 percent. In fact, the study—published in Clinical Gastroenterology and... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact,... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the... Continue Reading

Antiviral Therapy for Hepatitis C May Prevent Liver Cancer (November 2, 2012)

The use of antiviral drugs to treat patients with hepatitis C could greatly reduce their risk of developing liver cancer, according to the results of a study published in BMJ Open. The liver is the largest... Continue Reading

More Liver Cancer News

Latest Liver Cancer News By Stage


Screening/Prevention

Coffee Cuts Risk of Liver Cancer (November 8, 2013)

Good news for coffee addicts—new research has found that regular coffee consumption can reduce the risk of liver cancer by 40 percent. In fact, the study—published in Clinical Gastroenterology and Hepatology—found that people who consume more than... Continue Reading

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of Clinical Oncology.[1] The liver is the largest organ... Continue Reading

Antiviral Therapy for Hepatitis C May Prevent Liver Cancer (November 2, 2012)

The use of antiviral drugs to treat patients with hepatitis C could greatly reduce their risk of developing liver cancer, according to the results of a study published in BMJ Open. The liver is the largest organ in the body and is responsible for over... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Study Identifies Risk Factors Including Hepatitis C and Alcohol for Developing Hepatocellular Carcinoma (Liver Cancer) (March 12, 2012)

Liver cancer incidence has increased over time in the United States, and chronic infection with the hepatitis C virus now plays an important role in many cases. These results were published in Mayo Clinic Proceedings. The liver is the largest organ in... Continue Reading

More Screening and Prevention

Stages I-III

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading

Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading

Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)

Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical Oncology (ASCO) meeting. Hepatocellular carcinoma... Continue Reading

Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)

According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading

More Stages I and III

Stage IV

Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation (May 27, 2014)

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar® (sorafenib). This was recently announced in a press... Continue Reading

Factors Affecting Quality of Life at the End of Life (July 20, 2012)

For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have less to do with medical treatment and more to do with a therapeutic alliance with their physicians, according to the results of... Continue Reading

Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading

Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)

Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical Oncology (ASCO) meeting. Hepatocellular carcinoma... Continue Reading

More Stage IV

Recurrent

Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation (May 27, 2014)

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar® (sorafenib). This was recently announced in a press... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading

Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)

The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients. These results will be presented at the 2011 annual... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading

Arterial Embolization Effective in Patients with Liver Cancer Recurrence (June 26, 2006)

Arterial Embolization Effective in Patients with Liver Cancer Recurrence In selected patients who have a cancer recurrence following surgical removal of liver cancer, arterial embolization (blocking the arteries that supply blood to a tumor) appears to... Continue Reading

More Recurrent

Hepatocellular Carcinoma

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading

Oncology Experts Talk About Surgery, Ablation, Embolization, Radiation Therapy, Chemotherapy, and Clinical Trials for Primary Hepatocellular Carcinoma (Liver Cancer) (April 20, 2012)

In a recent Web Chat on CancerConnect.com, Dr. Boris Kuvshinoff II and Dr. Renuka Iyer, Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer Institute, presented a review of treatment options for primary liver cancer. Each year in... Continue Reading

Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading

More Hepatocellular Carcinoma

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS